4DMedical Ltd's stock soared 6.34% during intraday trading on Wednesday, following news of significant institutional investment in the company.
The surge came after the company disclosed that JPMorgan Chase & Co. and its affiliates have acquired a 5.27% voting stake in 4DMedical, making them a substantial holder according to a filing with the Australian bourse. JPMorgan now holds approximately 31.4 million ordinary shares in the medical technology firm.
Such institutional investment from a major financial player like JPMorgan Chase typically signals confidence in the company's prospects and can attract additional investor interest, potentially driving up the stock price.